Status:
COMPLETED
Para Aortic Lymphadenectomy : Always ?
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Cervical cancer affects more than 3000 new cases per year in France. The treatment of stage IB3 to IVA cervical cancer is based on concomitant radio-chemotherapy. The irradiation volumes are based, ac...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Patients with :
- locally advanced cervical cancer,
- who undergone PAL
- with pre operative PET CT, between January 2015 and december 2019
- Exclusion criteria:
- \- patients aged under 18
Exclusion
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04392895
Start Date
January 1 2017
End Date
June 30 2020
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295